110 likes | 132 Views
CRAG members actively participate in various working groups, conferences, and advocacy efforts to enhance community engagement in TB research and improve access to treatment options.
E N D
Community Research Advisors Groupto theTuberculosis Trials Consortium May 16, 2013 Atlanta, GA Francis A, CRAG member, Site 39 Mike Frick, CRAG coordinator; Treatment Action Group
Membership Update *CRAG co-chair
CRAG Working Group Participation • CRAG members continue to participate in many working groups and protocol development teams: • Other working groups should contact CRAG at key milestones in process for feedback • AER • CSG • IQC • LTBI • MDR • PIG • P&P • Ph II • Ph III • Biomarkers • Steering Committee
CRAG Member Achievements since October 2012 • 2 new Community Advisory Boards (CABs) formed • Uganda • Peru • Co-authored Lancet Infectious Diseases publication on community engagement in TB research • “Engaging communities in TB Research,”Lancet ID (2013) • World TB Day activities and advocacy • South Texas World TB Day walk / run • Congressional meetings in Washington, D.C. • Awareness raising through social media (diamundialtb.org)
CRAG Achievements: Media “TB’s global resurgence amplifies US risk” Dec 18, 2012 “TB, a neglected disease in Uganda” May 15, 2013
CRAG Achievements: conference submissions • CRAG submitted an abstract on M&E for community engagement in TB research to the • Dorothy Namutamba also submitted an abstracts to the Union Conference • Barbara Seaworth will present on abstract at the NTCA annual meeting
Ongoing CRAG activities • Finalizing an M&E framework for CRAG member activities • Support from LakshmyMenon, CDC Field Services and Evaluation Branch • Measures CRAG impact across multiple levels: • TBTC • Communities • Trial sites • Policymakers • CRAG members • Measures CRAG impact in multiple domains: • knowledge • attitudes • practices
Ongoing CRAG Activities • Advocating for increased access to sutezolid and rifapentine for TB programs and research consortia • Advocating for increased funding and political will for TB research • - Translated Treatment Action Group TB R&D Funding Report into Spanish
Upcoming CRAG Activities • Supporting Good Participatory Practice guidelines adoption in TB drug trials - Workshop on community engagement at Union conference - NIH R21 Grant on GPP • Consulting on S29x informed consent evaluation survey • Increasing CRAG involvement in reviewing early drafts of protocols • Increasing CRAG involvement in disseminating research findings to study participants